Understanding Medullary Thyroid Carcinoma (MTC)

It is completely normal to feel a sense of panic or overwhelm when you hear the words “Medullary Thyroid Carcinoma” (MTC). Because MTC is rare—accounting for only about 1% to 2% of all thyroid cancer cases—you may find that even friends or family members who have had “common” thyroid cancer don’t fully understand your experience ^[1].

While the diagnosis is serious, MTC is a well-studied disease with a very specific “roadmap” for treatment. This page will help you orient yourself to what MTC is and why it behaves differently than other thyroid conditions.

What is Medullary Thyroid Carcinoma?

Most thyroid cancers start in the cells that produce thyroid hormone (follicular cells). MTC is fundamentally different because it starts in the C-cells (also called parafollicular cells) ^[1].

These C-cells are part of the neuroendocrine system, meaning they have features of both nerve cells and hormone-producing cells ^[1]. Their primary job is to produce a hormone called calcitonin, which helps regulate calcium levels in the body ^[2]. Because MTC arises from these specific cells, it does not respond to treatments like radioactive iodine, which only works on follicular cells.

Three Stabilizing Facts

When you are first diagnosed, it can feel like you are losing control. Here are three facts to help anchor your perspective:

1. Your cancer has a “fingerprint”: Unlike many other cancers, MTC produces a specific protein called calcitonin that can be measured with a simple blood test ^[2]. This acts as a highly sensitive biomarker, allowing your doctors to “see” the cancer’s activity and monitor how well treatments are working without always needing invasive scans ^[3][4].
2. Modern “Targeted” treatments are available: In the past decade, there has been a revolution in MTC treatment. If surgery is not enough, we now have highly effective targeted therapies—drugs like selpercatinib and pralsetinib—that specifically “turn off” the genetic signals (like the RET mutation) that tell the cancer to grow ^[5][6].
3. Hereditary cases are highly manageable: About 25% of MTC cases are hereditary (part of a syndrome called MEN2) ^[7]. Because we know exactly which gene (RET) causes this, family members can be tested early. When caught at the earliest stages in family members, MTC can often be prevented or cured through a prophylactic (preventative) surgery ^[8].

Why MTC is Different

It is important to understand that MTC is not just a “rare version” of common thyroid cancer; it is a different disease entirely.

Your First Steps

Because MTC is unique, your initial workup will include two critical steps that other thyroid patients might not have:

• RET Genetic Testing: Every person diagnosed with MTC should have a blood test to see if they carry a mutation in the RET proto-oncogene ^[10]. This tells your doctor if your cancer is “sporadic” (just you) or “hereditary” (could affect your family).
• Pheochromocytoma Screening: Before any surgery, your doctor must rule out a pheochromocytoma—a rare, usually non-cancerous tumor of the adrenal gland that can sometimes occur alongside MTC in hereditary cases ^[11]. If present, it must be treated before thyroid surgery to ensure your blood pressure stays safe during the operation.